XXXX : long term outcomes of Billroth I reconstruction at a single European institute.

@entity1 @entity5 @entity356
BACKGROUND/AIMS: The role of Billroth I (BI) subtotal gastrectomy (SG) for @entity356 ( @entity356 ) remains controversial in Western countries. The aim of the study is to critically analyze the long term outcomes of this procedure in a large single-institution experience. METHODOLOGY: Between 1990 and 2004, 158 @entity1 underwent BI SG for @entity356 at the Regina Elena Cancer Institute of Rome. Evaluation focused on @entity5 recurrence of the @entity356 , functional outcome and endoscopic findings. RESULTS: Actuarial survival rate 10 years after resection in stage I-II was 70.7 per cent. After curative resection, primary @entity356 occurred in one @entity1 seven years after resection (0.7 per cent), whereas two @entity1 had early recurrence (1.4 per cent) one and three years postoperatively. There were no oesophageal @entity5 . In survivors, Visick grades I and II achieved 95 per cent, and postoperative endoscopy showed no evidence of mucosal changes in 85 per cent of the @entity1 . Twelve per cent of the @entity1 took acid blocker regularly, however, the incidence of functional failure was 5 per cent. CONCLUSIONS: In selected @entity1 , Billroth I subtotal gastrectomy is a safe and effective procedure that provides long-term survival and very good functional outcome.
